- Home
- SGHT vs NRO Comparison
SGHT vs NRO Comparison
Compare SGHT & NRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- NRO
- Stock Information
- Founded
- SGHT 2011
- NRO 2003
- Country
- SGHT United States
- NRO United States
- Employees
- SGHT N/A
- NRO N/A
- Industry
- SGHT Medical Specialities
- NRO Finance/Investors Services
- Sector
- SGHT Health Care
- NRO Finance
- Exchange
- SGHT Nasdaq
- NRO Nasdaq
- Market Cap
- SGHT 193.2M
- NRO 199.6M
- IPO Year
- SGHT 2021
- NRO N/A
- Fundamental
- Price
- SGHT $5.24
- NRO $3.20
- Analyst Decision
- SGHT Buy
- NRO
- Analyst Count
- SGHT 8
- NRO 0
- Target Price
- SGHT $4.50
- NRO N/A
- AVG Volume (30 Days)
- SGHT 221.6K
- NRO 239.4K
- Earning Date
- SGHT 11-06-2025
- NRO 01-01-0001
- Dividend Yield
- SGHT N/A
- NRO 11.41%
- EPS Growth
- SGHT N/A
- NRO N/A
- EPS
- SGHT N/A
- NRO N/A
- Revenue
- SGHT $76,303,000.00
- NRO N/A
- Revenue This Year
- SGHT N/A
- NRO N/A
- Revenue Next Year
- SGHT $12.04
- NRO N/A
- P/E Ratio
- SGHT N/A
- NRO N/A
- Revenue Growth
- SGHT N/A
- NRO N/A
- 52 Week Low
- SGHT $2.03
- NRO $2.51
- 52 Week High
- SGHT $5.52
- NRO $3.45
- Technical
- Relative Strength Index (RSI)
- SGHT 76.45
- NRO 52.01
- Support Level
- SGHT $3.22
- NRO $3.12
- Resistance Level
- SGHT $5.32
- NRO $3.19
- Average True Range (ATR)
- SGHT 0.31
- NRO 0.03
- MACD
- SGHT 0.22
- NRO 0.00
- Stochastic Oscillator
- SGHT 93.93
- NRO 84.47
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").